Drug formulators should consider the physical properties of their products during pharmaceutical drug development. The physical properties of a solid drug substance are highly dependent on the solid form. It is critical to understand the solid form landscape and select the optimum solid form for drug performance, stability and manufacturability as early in the development process as possible. Join this free webinar to learn about different solid forms (polymorph and salt) and different technologies to achieve these forms (cocrystal and dispersion).
Dr. Steef Boerrigter, Senior Research Scientist, AMRI
Dr. Steef Boerrigter is currently a group leader in Materials Science at AMRI. Beyond performing experimental screening for polymorphs, salts and cocrystals, his group specializes in crystal growth for single-crystal structure elucidation and is investigating computational methods for virtual coformer screening. Dr. Boerrigter obtained his PhD in Materials Science from Nijmegen University (Netherlands) on the subject of crystal morphology prediction. In 2002 he moved to Antwerp, Belgium where he worked on a Marie-Curie postdoctoral fellowship at the imaging company Agfa-Gevaert. He has been associated with the Industrial and Physical Pharmacy Department in the College of Pharmacy at Purdue University since 2003 and currently serves as an adjunct assistant professor.
Who Should Attend?
This webinar will appeal to senior level professionals from pharmaceutical and biotechnology companies and research/academic institutions.
- Chemistry / Process Chemistry / Medicinal Chemistry
- Analytical Chemistry
- Analytical R&D
- Clinical Operations
- Chief Scientific Officers
- Research Scientists
What You Will Learn
Attendees will learn about:
- Properties of solid drug substances
- Optimizing solid form selection for drug performance
- Various technologies for achieving solid form for inherently problematic substances
AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical and Solid State Services, API Manufacturing and Drug Product